Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-07

Clinical Trial Update: Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010 [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing allopurinol and febuxostat in subjects completing trials C02-009 and C02-010; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allopurinol (Allopurinol)
  • FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Takeda | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2009-09-07